[Antigenic modifications of cancerous cells].
作者信息
Jollès G, Maral R
出版信息
C R Acad Hebd Seances Acad Sci D. 1968 Oct 7;267(15):1241-4.
PMID:4972867
Abstract
摘要
相似文献
1
[Antigenic modifications of cancerous cells].
C R Acad Hebd Seances Acad Sci D. 1968 Oct 7;267(15):1241-4.
2
Rejection of lethal tumors after subcutaneous inoculation: a phenomenon of antigenic expression?
J Natl Cancer Inst. 1967 Dec;39(6):1129-39.
3
Growth of subcutaneous grafts of some clones of Ehrlich ascites tumor in mice of different strains.
Arch Immunol Ther Exp (Warsz). 1966;14(6):711-6.
4
Immunity against the Ehrlich ascites carcinoma produced by bacterial endotoxins.
Transplant Proc. 1969 Mar;1(1):124-5.
5
[Resistance to Ehrlich's ascites carcinoma in mice immunized with killed tumor cells].
Riv Ist Sieroter Ital. 1967 Nov-Dec;42(6):332-49.
6
Effect of subcutaneous transplants of Ehrlich carcinoma on the survival time of mice with intraperitoneal transplants of the same tumour.
J Pathol. 1971 Oct;105(2):85-93. doi: 10.1002/path.1711050202.
7
Interaction between subcutaneous and intraperitoneal transplants of the Ehrlich carcinoma; the possible role of anti-tumour antibody.
J Pathol. 1971 Oct;105(2):95-103. doi: 10.1002/path.1711050203.
8
[Detection of the antigenic properties of Ehrlich mouse carcinoma cells following their treatment with lonin-3 preparation].
Biull Eksp Biol Med. 1965 Nov;60(11):68-71.
9
Antitumor factor of regional lymph node cells in the transplantation of Ehrlich tumor cells. 3. Passive transfer of the antitumor factor.
Acta Med Okayama (1952). 1969 Aug;23(4):283-90.
引用本文的文献
1
Biological activities of rubidazone.
Cancer Chemother Pharmacol. 1979;2(1):31-5. doi: 10.1007/BF00253102.
Zotero 插件